Biomimetic oxidation of praziquantel catalysed by metalloporphyrins

[1]  Y. Iamamoto,et al.  Cationic manganese(III) porphyrins bound to a novel bis-functionalised silica as catalysts for hydrocarbons oxygenation by iodosylbenzene and hydrogen peroxide , 2001 .

[2]  M. G. D’Oca,et al.  Intrinsic gas-phase electrophilic reactivity of cyclic N-alkyl- and N-acyliminium ions. , 2001, The Journal of organic chemistry.

[3]  G. Blaschke,et al.  Capillary electrophoresis-mass spectrometry, liquid chromatography-mass spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[4]  S. Ekins,et al.  Present and future in vitro approaches for drug metabolism. , 2000, Journal of pharmacological and toxicological methods.

[5]  G. Blaschke,et al.  Investigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[6]  T. Traylor,et al.  Polyhaloporphyrins: Unusual Ligands for Metals and Metal-Catalyzed Oxidations , 1997 .

[7]  H. Gray,et al.  How do electronegative substituents make metal complexes better catalysts for the oxidation of hydrocarbons by dioxygen , 1997 .

[8]  M. Hirobe,et al.  Four recent studies in cytochrome P450 modelings: A stable iron porphyrin coordinated by a thiolate ligand; a robust ruthenium porphyrin-pyridine N-oxide derivatives system; polypeptide-bound iron porphyrin; application to drug metabolism studies , 1996 .

[9]  K. Ciuffi,et al.  Factors which affect the catalytic activity of iron(III) meso tetrakis(2,6-dichlorophenyl) porphyrin chloride in homogeneous system , 1996 .

[10]  D. R. Hill,et al.  Metalloporphyrins as chemical mimics of cytochrome P-450 systems , 1994 .

[11]  M. Abdel-Bary,et al.  Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure. , 1994, The American journal of tropical medicine and hygiene.

[12]  C. Masimirembwa,et al.  Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. , 1994, Biochemical pharmacology.

[13]  N. El-Masry,et al.  Monitoring the efficacy of different doses of praziquantel by quantification of circulating antigens in serum and urine of schistosomiasis patients , 1994, Parasitology.

[14]  B. Meunier,et al.  Model systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[15]  B. Meunier.  Metalloporphyrins as versatile catalysts for oxidation reactions and oxidative DNA cleavage , 1992 .

[16]  F. Westhoff,et al.  High-performance liquid chromatographic determination of the stereoselective biotransformation of the chiral drug praziquantel. , 1992, Journal of chromatography.

[17]  X. Shuhua,et al.  Plasma Pharmacokinetics and Therapeutic Efficacy of Praziquantel and 4-Hydroxypraziquantel in Schistosoma japonicum-Infected Rabbits after Oral, Rectal, and Intramuscular Administration , 1992 .

[18]  B. Meunier,et al.  Model systems for metabolism studies. Biomimetic oxidation of acetaminophen and ellipticine derivatives with water-soluble metalloporphyrins associated to potassium monopersulfate. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[19]  M. E. Mandour,et al.  Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  D. Mansuy,et al.  Chemical model systems for drug-metabolizing cytochrome-P-450-dependent monooxygenases. , 1989, European journal of biochemistry.

[21]  D. Mansuy,et al.  Monooxygenase-like oxidation of hydrocarbons by hydrogen peroxide catalyzed by manganese porphyrins and imidazole: selection of the best catalytic system and nature of the active oxygen species , 1988 .

[22]  J. Lindsey,et al.  Rothemund and Adler-Longo reactions revisited: synthesis of tetraphenylporphyrins under equilibrium conditions , 1987 .

[23]  J. Groves,et al.  Aliphatic hydroxylation catalyzed by iron porphyrin complexes , 1983 .

[24]  J. Groves,et al.  Hydroxylation and epoxidation catalyzed by iron-porphine complexes. Oxygen transfer from iodosylbenzene , 1979 .

[25]  G. Leopold,et al.  Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes , 1978, European Journal of Clinical Pharmacology.

[26]  F. Kampas,et al.  On the preparation of metalloporphyrins , 1970 .

[27]  J. Smith,et al.  Alkene epoxidation with iodosylbenzene catalysed by polyionic manganese porphyrins electrostatically bound to counter-charged supports , 2001 .

[28]  M. Hirobe,et al.  Application of chemical P-450 model systems to studies on drug metabolism. Part X. Novel hydroxylactonization of γ,δ- and β,γ- unsaturated carboxylic acids with an iron porphyrin–iodosylbenzene system , 1996 .

[29]  K. Ciuffi,et al.  Factors Affecting the Catalytic Activity of Aryl Substituted Ironporphyrins , 1995 .

[30]  S. Sakuda,et al.  Biosynthetic studies on virginiae butanolide A, a butyrolactone autoregulator from Streptomyces. Part 2. Preparation of possible biosynthetic intermediates and conversion experiments in a cell-free system , 1993 .